First- versus Third-Generation EGFR Tyrosine Kinase Inhibitors in EGFR-Mutated Non-Small Cell Lung Cancer Patients with Brain Metastases

Ahmad Ozair; Atulya Khosla; Shreya Saxena; Manmeet Ahluwalia

First- versus Third-Generation EGFR Tyrosine Kinase Inhibitors in EGFR-Mutated Non-Small Cell Lung Cancer Patients with Brain Metastases

Ahmad Ozair, Atulya Khosla, Shreya Saxena, Manmeet Ahluwalia

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Cancers
Volume	15
State	Published - Apr 20 2023

Access to Document

First- versus Third-Generation EGFR Tyrosine Kinase Inhibitors inFinal published version, 961 KBLicense: Unspecified

Cite this

@article{ec7f5fb958164148926735e77fedbf2a,

title = "First- versus Third-Generation EGFR Tyrosine Kinase Inhibitors in EGFR-Mutated Non-Small Cell Lung Cancer Patients with Brain Metastases",

author = "Ahmad Ozair and Atulya Khosla and Shreya Saxena and Manmeet Ahluwalia",

note = "Tatineni, V., O{\textquoteright}Shea, P. J., Ozair, A., Khosla, A. A., Saxena, S., Rauf, Y., Jia, X., Murphy, E. S., Chao, S. T., Suh, J. H., Peereboom, D. M., \& Ahluwalia, M. S. (2023). First- versus Third-Generation EGFR Tyrosine Kinase Inhibitors in EGFR-Mutated Non-Small Cell Lung Cancer Patients with Brain Metastases. Cancers, 15(8), 2382. https://www.mdpi.com/2072-6694/15/8/2382",

year = "2023",

month = apr,

day = "20",

language = "American English",

volume = "15",

journal = "Cancers",

}

TY - JOUR

T1 - First- versus Third-Generation EGFR Tyrosine Kinase Inhibitors in EGFR-Mutated Non-Small Cell Lung Cancer Patients with Brain Metastases

AU - Ozair, Ahmad

AU - Khosla, Atulya

AU - Saxena, Shreya

AU - Ahluwalia, Manmeet

N1 - Tatineni, V., O’Shea, P. J., Ozair, A., Khosla, A. A., Saxena, S., Rauf, Y., Jia, X., Murphy, E. S., Chao, S. T., Suh, J. H., Peereboom, D. M., & Ahluwalia, M. S. (2023). First- versus Third-Generation EGFR Tyrosine Kinase Inhibitors in EGFR-Mutated Non-Small Cell Lung Cancer Patients with Brain Metastases. Cancers, 15(8), 2382. https://www.mdpi.com/2072-6694/15/8/2382

PY - 2023/4/20

Y1 - 2023/4/20

UR - https://scholarlycommons.baptisthealth.net/se-all-publications/4805

M3 - Article

VL - 15

JO - Cancers

JF - Cancers

ER -

First- versus Third-Generation EGFR Tyrosine Kinase Inhibitors in EGFR-Mutated Non-Small Cell Lung Cancer Patients with Brain Metastases

Access to Document

Other files and links

Cite this